ERBB2 and neoplasm: Similar to OT-I T cells, CAR T cells directed against the Her2 antigen did not lose their function or viability upon infection with rVSV-MΔ51-GFP, and they were shown to maintain their antitumor effector functions and efficiently deliver virus to the tumor [156].